Agastiya Biotech
Agastiya Biotech is a clinical stage oncology drug development company which uses AI:Intuit-Serendipity, an AI platform invented by Dr. Pillai, founder of Agastiya Biotech. AB001, the first molecule created through our technology, completed Phase I trial in India and Phase II is scheduled for October 2024 in 30 centers across India. We have also completed preclinical work for a KRAS inhibitor and a molecule for diabetes. Our mission is to make our medicines in India for equitable access purpose.
7-day free trial · no credit card
Verified contacts
3
available on Kipplo
LinkedIn employees
6
1 to 10 range
Open roles
—
no listings
Distinct roles
3
indexed titles
Tech stack
0
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 3 verified contacts at Agastiya Biotech
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
3 contacts with verified email or phone · masked until revealed.
- BD
Beth Desmarais
Global Partner Relations · Other
EmailPhone - SB
Sonja Benkovich
() · Other
EmailPhone
Showing 2 of 3 verified contacts
Top roles at Agastiya Biotech
3 distinct titles indexed · top 3 shown.
- 1()
- 1global partner relations
- 1telicaller
Sign up to unlock all 3 contacts at Agastiya Biotech
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 3 verified contacts at Agastiya Biotech
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.